How should women with pre-eclampsia be followed up? New insights from mechanistic studies
Alexandre Hertig*, Suzanne Watnick, Helena Strevens, Henri Boulanger, Nadia Berkane and Eric Rondeau
Correspondence *Urgences Néphrologiques et Transplantation Rénale, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France
Email alexandre.hertig@tnn.aphp.fr
Considerable progress has been made over the past few years in understanding the pathogenesis of pre-eclampsia. In particular, the contribution of the circulating antiangiogenic factors soluble fms-like tyrosine kinase 1 and endoglin to the vascular and glomerular dysfunction of pre-eclampsia has been recognized. Inspired by these findings, Alexandre Hertig and colleagues from France, the US and Switzerland propose an updated and standardized protocol for the post-delivery follow-up of women with pregnancy-induced hypertension or pre-eclampsia.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
